Immunotherapy
The future of mesothelioma treatment could very well be immunotherapy. Keytruda, which is used in the treatment of some types of lung cancer, is closer than ever to FDA approval for the treatment of mesothelioma.
Mesothelioma specialists focus on Merck’s lung cancer drug Keytruda. Read more.
Mesothelioma Research News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
